-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Bellicum Pharmaceuticals, Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2013 to 2022.
- Bellicum Pharmaceuticals, Inc Nonoperating Income (Expense) for the quarter ending September 30, 2023 was $10K.
- Bellicum Pharmaceuticals, Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2023 was $1.45M, a 82.9% decline year-over-year.
- Bellicum Pharmaceuticals, Inc annual Nonoperating Income (Expense) for 2022 was $2.01M, a 86.7% decline from 2021.
- Bellicum Pharmaceuticals, Inc annual Nonoperating Income (Expense) for 2021 was $15.2M, a 65.5% decline from 2020.
- Bellicum Pharmaceuticals, Inc annual Nonoperating Income (Expense) for 2020 was $44M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)